Figure 1.

Incremental Cost Effectiveness Ratio (ICER) per Quality Adjusted Life Year (QALY) among different subgroups and based on the population from WRAP-IT trial. Results are shown for Europe (A) as reported by Boriani et al. (54) and in US (B) as reported by Wilkoff et al. (55). The dashed lines represent the willingness to pay threshold for each country. The values for UK have been recalculated in Euro to facilitate comparability. CIED–cardiac implantable electronic device, CRT-D–cardiac resynchronization defibrillator, CRT-P–cardiac resynchronization pacemaker, ICD–implantable cardioverter defibrillator, PM–pacemaker.